Gemcitabine: A promising new agent in the treatment of advanced urothelial cancer

Journal of Clinical Oncology

Volumn 15, Issue 12, 1997, Pages 3441-3445

  Moore, Malcolm J ^a   Tannock, Ian F ^a   Ernst, D Scott ^a   Huan, Susan ^a   Murray, Nevin ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; GALLIUM NITRATE; GEMCITABINE; METHOTREXATE; PACLITAXEL; VINBLASTINE;

ADVANCED CANCER; AGED; ARTICLE; BLADDER CARCINOMA; BLOOD TOXICITY; CANCER CONTROL; CANCER GROWTH; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SKIN TOXICITY; THROMBOEMBOLISM; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

EID: 0030686593     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.12.3441     Document Type: Article

References (15)

1. Moore MJ, Tannock IF: Chemotherapy of bladder cancer. Adv Urol 6:127-156, 1993
2. Sternberg CN, Yagoda A, Scher HI, et al: Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 64:2448-2458, 1989
3. Loehrer PJ, Einhorn LH, Elson PJ, et al: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma. J Clin Oncol 10:1066-1073, 1992
4. Fossa SD, Sternberg C, Scher HI, et al: Survival of patients with advanced urothelial cancer treated with cisplatin based therapy. Br J Cancer 74:1655-1659, 1996
5. Saxman SB, Loehrer PJ, Propert K, et al: Long term follow up of phase III intergroup study of M-VAC vs. cisplatin in metastatic urothelial carcinoma. Proc Am Soc Clin Oncol 15:631, 1996 (abstr)
6. Hertel LW, Boder GB, Kroin JS, et al: Evaluation of the antitumor activity of gemcitabine. Cancer Res 50:4417-4422, 1990
7. Huang P, Chubb S, Hertel LW, et al: Action of gemcitabine on DNA synthesis. Cancer Res 51:6110-6117, 1991
8. Pollera CF, Ceribelli A, Crecco M, et al: Weekly gemcitabine in advanced bladder cancer. Ann Oncol 5:182-185, 1994
9. Czaykowski P, Moore MJ, Tannock IF: Arterial and venous vascular events patients receiving chemotherapy for transitional cell carcinoma. Proc Am Soc Clin Oncol 16:1181, 1997 (abstr)
10. Crino L, Scaglotti G, Marangolo M, et al: Cisplatin-gemcitabine combination in non-small cell lung cancer. A phase II study. Proc Am Soc Clin Oncol 14:1066, 1995 (abstr)
11. Roth BJ, Dreicer R, Einhorn LH, et al: Significant activity of paclitaxel in advanced transitional cell carcinoma of the urothelium: A phase II trial of the Eastern Co-operative Oncology Group. J Clin Oncol 12:2264-2270, 1994
12. Einhorn LH, Roth BJ, Ansari R, et al: Phase 11 trial of vinblastine, ifostamide and gallium combination chemotherapy in metastatic urothelial carcinoma. J Clin Oncol 12:2271-2276, 1994
13. Seidman AD, Scher HI, Heinemann MH, et al: Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors. Cancer 68:1561-1565, 1991
14. Seligman PA, Crawford ED: Treatment of advanced transitional cell carcinoma of the bladder with continuous infusion gallium nitrate. J Natl Cancer Inst 83:1582-1584, 1991
15. Hillcoat BL, Raghavan D, Matthews J, et al: A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract. J Clin Oncol 7:706-709, 1989